302 related articles for article (PubMed ID: 26907172)
1. Transketolase-like 1 ectopic expression is associated with DNA hypomethylation and induces the Warburg effect in melanoma cells.
Jayachandran A; Lo PH; Chueh AC; Prithviraj P; Molania R; Davalos-Salas M; Anaka M; Walkiewicz M; Cebon J; Behren A
BMC Cancer; 2016 Feb; 16():134. PubMed ID: 26907172
[TBL] [Abstract][Full Text] [Related]
2. TKTL1 is activated by promoter hypomethylation and contributes to head and neck squamous cell carcinoma carcinogenesis through increased aerobic glycolysis and HIF1alpha stabilization.
Sun W; Liu Y; Glazer CA; Shao C; Bhan S; Demokan S; Zhao M; Rudek MA; Ha PK; Califano JA
Clin Cancer Res; 2010 Feb; 16(3):857-66. PubMed ID: 20103683
[TBL] [Abstract][Full Text] [Related]
3. Transketolase-like protein 1 (TKTL1) is required for rapid cell growth and full viability of human tumor cells.
Xu X; Zur Hausen A; Coy JF; Löchelt M
Int J Cancer; 2009 Mar; 124(6):1330-7. PubMed ID: 19065656
[TBL] [Abstract][Full Text] [Related]
4. Enhanced TKTL1 expression in malignant tumors of the ocular adnexa predicts clinical outcome.
Lange CA; Tisch-Rottensteiner J; Böhringer D; Martin G; Schwartzkopff J; Auw-Haedrich C
Ophthalmology; 2012 Sep; 119(9):1924-9. PubMed ID: 22658715
[TBL] [Abstract][Full Text] [Related]
5. Hypoxia induces the expression of transketolase-like 1 in human colorectal cancer.
Bentz S; Cee A; Endlicher E; Wojtal KA; Naami A; Pesch T; Lang S; Schubert P; Fried M; Weber A; Coy JF; Goelder S; Knüchel R; Hausmann M; Rogler G
Digestion; 2013; 88(3):182-92. PubMed ID: 24193262
[TBL] [Abstract][Full Text] [Related]
6. TKTL1 promotes cell proliferation and metastasis in esophageal squamous cell carcinoma.
Li J; Zhu SC; Li SG; Zhao Y; Xu JR; Song CY
Biomed Pharmacother; 2015 Aug; 74():71-6. PubMed ID: 26349965
[TBL] [Abstract][Full Text] [Related]
7. Expression of transketolase TKTL1 predicts colon and urothelial cancer patient survival: Warburg effect reinterpreted.
Langbein S; Zerilli M; Zur Hausen A; Staiger W; Rensch-Boschert K; Lukan N; Popa J; Ternullo MP; Steidler A; Weiss C; Grobholz R; Willeke F; Alken P; Stassi G; Schubert P; Coy JF
Br J Cancer; 2006 Feb; 94(4):578-85. PubMed ID: 16465194
[TBL] [Abstract][Full Text] [Related]
8. Expression of transketolase-like 1 protein (TKTL1) in human endometrial cancer.
Krockenberger M; Engel JB; Schmidt M; Kohrenhagen N; Häusler SF; Dombrowski Y; Kapp M; Dietl J; Honig A
Anticancer Res; 2010 May; 30(5):1653-9. PubMed ID: 20592357
[TBL] [Abstract][Full Text] [Related]
9. TKTL1 expression in human malign and benign cell lines.
Kämmerer U; Gires O; Pfetzer N; Wiegering A; Klement RJ; Otto C
BMC Cancer; 2015 Jun; 15():2. PubMed ID: 26187043
[TBL] [Abstract][Full Text] [Related]
10. Expression patterns and prognostic role of transketolase-like 1 in muscle-invasive bladder cancer.
Semilia M; Hennenlotter J; Pavone C; Bischoff T; Kühs U; Gakis G; Bedke J; Stenzl A; Schwentner C; Todenhöfer T
World J Urol; 2015 Oct; 33(10):1403-9. PubMed ID: 25572961
[TBL] [Abstract][Full Text] [Related]
11. Silencing of TKTL1 by siRNA inhibits proliferation of human gastric cancer cells in vitro and in vivo.
Yuan W; Wu S; Guo J; Chen Z; Ge J; Yang P; Hu B; Chen Z
Cancer Biol Ther; 2010 May; 9(9):710-6. PubMed ID: 20200485
[TBL] [Abstract][Full Text] [Related]
12. Gene Suppression of Transketolase-Like Protein 1 (TKTL1) Sensitizes Glioma Cells to Hypoxia and Ionizing Radiation.
Heller S; Maurer GD; Wanka C; Hofmann U; Luger AL; Bruns I; Steinbach JP; Rieger J
Int J Mol Sci; 2018 Jul; 19(8):. PubMed ID: 30044385
[TBL] [Abstract][Full Text] [Related]
13. Thrombospondin-1 expression in melanoma is blocked by methylation and targeted reversal by 5-Aza-deoxycytidine suppresses angiogenesis.
Lindner DJ; Wu Y; Haney R; Jacobs BS; Fruehauf JP; Tuthill R; Borden EC
Matrix Biol; 2013 Mar; 32(2):123-32. PubMed ID: 23202046
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of transketolase protein TKTL1 is associated with occurrence and progression in nasopharyngeal carcinoma: a potential therapeutic target in nasopharyngeal carcinoma.
Zhang S; Yue JX; Yang JH; Cai PC; Kong WJ
Cancer Biol Ther; 2008 Apr; 7(4):517-22. PubMed ID: 18296915
[TBL] [Abstract][Full Text] [Related]
15. A key role for transketolase-like 1 in tumor metabolic reprogramming.
Diaz-Moralli S; Aguilar E; Marin S; Coy JF; Dewerchin M; Antoniewicz MR; Meca-Cortés O; Notebaert L; Ghesquière B; Eelen G; Thomson TM; Carmeliet P; Cascante M
Oncotarget; 2016 Aug; 7(32):51875-51897. PubMed ID: 27391434
[TBL] [Abstract][Full Text] [Related]
16. TKTL1 modulates the response of paclitaxel-resistant human ovarian cancer cells to paclitaxel.
Zheng X; Li H
Biochem Biophys Res Commun; 2018 Sep; 503(2):572-579. PubMed ID: 29885837
[TBL] [Abstract][Full Text] [Related]
17. Transketolase protein TKTL1 overexpression: A potential biomarker and therapeutic target in breast cancer.
Földi M; Stickeler E; Bau L; Kretz O; Watermann D; Gitsch G; Kayser G; Zur Hausen A; Coy JF
Oncol Rep; 2007 Apr; 17(4):841-5. PubMed ID: 17342325
[TBL] [Abstract][Full Text] [Related]
18. Knockdown of TKTL1 additively complements cisplatin-induced cytotoxicity in nasopharyngeal carcinoma cells by regulating the levels of NADPH and ribose-5-phosphate.
Dong Y; Wang M
Biomed Pharmacother; 2017 Jan; 85():672-678. PubMed ID: 27916418
[TBL] [Abstract][Full Text] [Related]
19. Tumor antigen PRAME is up-regulated by MZF1 in cooperation with DNA hypomethylation in melanoma cells.
Lee YK; Park UH; Kim EJ; Hwang JT; Jeong JC; Um SJ
Cancer Lett; 2017 Sep; 403():144-151. PubMed ID: 28634046
[TBL] [Abstract][Full Text] [Related]
20. Expression of the mutated transketolase TKTL1, a molecular marker in gastric cancer.
Staiger WI; Coy JF; Grobholz R; Hofheinz RD; Lukan N; Post S; Schwarzbach MH; Willeke F
Oncol Rep; 2006 Oct; 16(4):657-61. PubMed ID: 16969476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]